» Authors » Karen E Mate

Karen E Mate

Explore the profile of Karen E Mate including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 89
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yabang W, Manning E, Mate K, Endacott S, Cameron G, Cameron G
Immunol Cell Biol . 2025 Feb; 103(3):256-264. PMID: 40016869
Indigenous representation in Australian biomedical science and pharmacy research remains limited due to systemic barriers, historical marginalization and culturally inappropriate educational frameworks. This article outlines a case study of initiatives...
2.
Mate K, Barnett M, Kerr K, Pond C, Magin P
Fam Pract . 2019 Dec; 37(3):314-320. PMID: 31784733
Background: It is recommended that anticholinergic medication is avoided in older people, especially those with cognitive impairment. Objective: To investigate anticholinergic load (ACL) over time in older primary care patients...
3.
Brodaty H, Connors M, Loy C, Teixeira-Pinto A, Stocks N, Gunn J, et al.
Dement Geriatr Cogn Disord . 2016 Nov; 42(5-6):323-330. PMID: 27811463
Background/aims: The General Practitioner Assessment of Cognition (GPCOG) is a brief cognitive test. This study compared the GPCOG to the Mini-Mental State Examination (MMSE), the most widely used test, in...
4.
Mate K, Magin P, Brodaty H, Stocks N, Gunn J, Disler P, et al.
Int J Geriatr Psychiatry . 2016 Mar; 32(3):316-323. PMID: 26988976
Objective: General practitioners (GPs) fail to identify more than 50% of dementia cases using the existing passive case-finding approach. Using data from the "Ageing in General Practice" study, we sought...
5.
Mate K, Kerr K, Pond D, Williams E, Marley J, Disler P, et al.
Drugs Aging . 2015 Jan; 32(2):159-67. PMID: 25566958
Background: Elderly people, particularly those with dementia, are sensitive to adverse anticholinergic drug effects. This study examines the prevalence of anticholinergic medication, and anticholinergic load and its predictors, in community-dwelling...
6.
Pond C, Mate K, Phillips J, Stocks N, Magin P, Weaver N, et al.
Int Psychogeriatr . 2013 Jun; 25(10):1639-47. PMID: 23800652
Background: Dementia is a complex and variable condition which makes recognition of it particularly difficult in a low prevalence primary care setting. This study examined the factors associated with agreement...
7.
Mate K, Pond C, Magin P, Goode S, McElduff P, Stocks N
Int Psychogeriatr . 2012 Aug; 24(12):1962-71. PMID: 22874650
Background: Identification of factors associated with quality of life (QoL) in people having dementia will help develop strategies for maintenance and improvement of patient QoL. This study examined the predictors...
8.
Pond C, Brodaty H, Stocks N, Gunn J, Marley J, Disler P, et al.
BMC Fam Pract . 2012 Mar; 13:12. PMID: 22397614
Background: Dementia is increasing in prevalence as the population ages. An earlier rather than later diagnosis allows persons with dementia and their families to plan ahead and access appropriate management....
9.
Kitchener A, Kay D, Walters B, Menkhorst P, McCartney C, Buist J, et al.
J Reprod Immunol . 2009 Aug; 82(1):40-7. PMID: 19709753
To evaluate the potential contraceptive effect of immunisation with zona pellucida antigens, 50 free-ranging koalas were immunised with either porcine zonae pellucidae (PZP), recombinant brushtail possum ZP3 (recBP-ZP3) or buffer,...
10.
Kitchener A, Harman A, Kay D, McCartney C, Mate K, Rodger J
J Reprod Immunol . 2009 Feb; 79(2):156-62. PMID: 19215986
This study examined the potential of a recombinant marsupial zona pellucida 3 protein as a contraceptive vaccine for the Eastern Grey kangaroo, a marsupial that is locally overabundant in several...